Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

N1-(5-acetylpyridin-2-yl)-N2-(5-chloropyridin-2-yl)ethanediamide

● In Stock

Catalogue No.:	VE0025785
CAS No.:	N/A
Mol. Formula:	C14H11ClN4O3
Mol. Weight:	318.72 g/mol

Request a quote

Add to RFQ list

Additional information on

Parent drug

Edoxaban

IUPAC Name

N1-(5-acetylpyridin-2-yl)-N2-(5-chloropyridin-2-yl)ethanediamide

Pharmacopeial Synonyms

N/A

Synonyms

N1-(5-acetylpyridin-2-yl)-N2-(5-chloropyridin-2-yl)oxalamide

Smiles

CC(C1=CN=C(NC(C(NC2=NC=C(Cl)C=C2)=O)=O)C=C1)=O

InChI

InChI=1S/C14H11ClN4O3/c1-8(20)9-2-4-11(16-6-9)18-13(21)14(22)19-12-5-3-10(15)7-17-12/h2-7H,1H3,(H,16,18,21)(H,17,19,22)

Description

N1-(5-acetylpyridin-2-yl)-N2-(5-chloropyridin-2-yl)ethanediamide is a process-related impurity characterized by a substituted pyridinyl acetyl and a 5-chloro pyridinyl moiety, commonly encountered in oxalamide synthetic sequences. The impurity displays moderate polarity and thermal stability, causing partial coelution in reversed-phase HPLC and requiring sensitive detection. Reliable identification and quantification are achieved by LC-MS supported by 1H and 13C NMR and UV detection at 254 nm. Its presence can compromise API purity and crystallization behavior. Control strategies include optimized stoichiometry and reaction conditions, targeted purification such as preparative HPLC or recrystallization, and routine in-process monitoring with validated analytical methods.